Skip to main content

Table 2 Clinical and demographic characteristics of participants in the validation study

From: Development and psychometric properties of the Suicidality: Treatment Occurring in Paediatrics (STOP) Suicidality Assessment Scale (STOP-SAS) in children and adolescents

Participants

Adolescents

n = 576 (%)a

Children

n = 187 (%)a

Diagnoses DSM-IV-TR*

 Eating disorder

65 (6.1)

0

 Major Depressive Disorder (MDD)

258 (24)

16 (3.9)

 Attention Deficit Hyperactivity Disorder (ADHD)

153 (14.3)

127 (30.6)

 Conduct Disorder/Oppositional Defiant Disorder (CD/ODD)

89 (8.3)

60 (14.5)

 Bipolar Disorder

39 (3.6)

6 (1.4)

 Schizophrenia and Other Psychotic Disorders

36 (3.4)

0

 Anxiety Disorders

129 (12)

35 (8.4)

 Pervasive Developmental Disorders

114 (10.6)

67 (16.1)

 Tic Disorders

25 (2.3)

13 (3.1)

 Substance Related Disorders

14 (1.3)

0

 Mental Retardation

55 (5.1)

35 (8.4)

 Learning Disorders

20 (1.9)

12 (2.9)

 Other Disorders

76 (7.1)

44 (10.6)

Pharmacological treatment

 Antipsychotics

367 (41)

143 (48)

 Antidepressants

265 (29.6)

22 (7.4)

 Stimulants

60 (6.7)

68 (22.8)

 Mood stabilizers and Lithium

46 (5.1)

10 (3.4)

 Benzodiazepines

36 (4)

1 (0.3)

 Other psychiatric pharmacological treatments

56 (6.3)

35 (11.7)

 Non-psychiatric pharmacological treatments

64 (7.1)

19 (6.6)

 No pharmacological treatment

68 (11.08)b

19 (10.16)b

  1. * DSM-IV-TR = The Diagnostic and Statistical Manual of Mental Disorders. Fourth edition, text revised
  2. a Percentage considering the total number of medications and diagnoses
  3. b Number of patients and percentage considering total number of patients